Maximus, Inc. (NYSE:MMS) Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC grew its position in Maximus, Inc. (NYSE:MMS) by 70.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,145 shares of the health services provider’s stock after purchasing an additional 4,196 shares during the period. Janney Montgomery Scott LLC’s holdings in Maximus were worth $692,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. UMB Bank n.a. lifted its position in Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 250 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider’s stock valued at $50,000 after buying an additional 294 shares during the period. IFP Advisors Inc lifted its holdings in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after buying an additional 302 shares during the period. Farther Finance Advisors LLC boosted its stake in shares of Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider’s stock worth $61,000 after buying an additional 428 shares during the last quarter. Finally, NBC Securities Inc. grew its holdings in Maximus by 114,900.0% during the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider’s stock worth $78,000 after acquiring an additional 1,149 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Gayathri Rajan sold 7,913 shares of the business’s stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the sale, the director owned 14,205 shares of the company’s stock, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a report on Thursday, May 15th.

Maximus Stock Performance

Shares of NYSE MMS opened at $71.67 on Wednesday. The company has a market capitalization of $4.04 billion, a PE ratio of 14.25 and a beta of 0.61. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.84 and a current ratio of 1.84. The company’s fifty day moving average price is $70.94 and its 200 day moving average price is $70.92. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.64. Maximus had a net margin of 5.56% and a return on equity of 23.37%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the prior year, the firm posted $1.57 earnings per share. The company’s revenue was up 1.0% compared to the same quarter last year. On average, research analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.67%. The ex-dividend date was Thursday, May 15th. Maximus’s payout ratio is 23.86%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.